Pacira BioSciences, Inc. (PCRX) stock
PCRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3034% above fair value
$36.34+0.00 (0.00%)
Close on Oct 19, 2026Market cap $1.45BP/E 103.8Yield –
Pacira BioSciences market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Pacira BioSciences's market cap was $1.45B on Nov 11, 2026, against $1.01B a year earlier. Over the last 5 years it ranged from $694.07M to $3.41B, with a median of $1.33B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.45B | +30.6% |
| 2025 | Dec 31, 2025 | $1.11B | +27.9% |
| 2024 | Dec 31, 2024 | $869.43M | -44.5% |
| 2023 | Dec 29, 2023 | $1.57B | -11.5% |
| 2022 | Dec 30, 2022 | $1.77B | -33.9% |
| 2021 | Dec 31, 2021 | $2.68B | +3.4% |
| 2020 | Dec 31, 2020 | $2.59B | +37.2% |
| 2019 | Dec 31, 2019 | $1.89B | +6.9% |
| 2018 | Dec 31, 2018 | $1.77B | -4.6% |
| 2017 | Dec 29, 2017 | $1.85B | +53.8% |
| 2016 | Dec 30, 2016 | $1.20B | -57.3% |
| 2015 | Dec 31, 2015 | $2.82B | -11.7% |
| 2014 | Dec 31, 2014 | $3.19B | +65.8% |
| 2013 | Dec 31, 2013 | $1.93B | +239.5% |
| 2012 | Dec 31, 2012 | $567.47M | +280.8% |
| 2011 | Dec 30, 2011 | $149.03M | – |
See a number that looks wrong?